Lyfebulb and TRIO Announce Partnership on Digital Engagement Platform for Transplant Community
News provided by
Share this article
Share this article
NEW YORK, Feb. 3, 2021 /PRNewswire/ Patient empowerment platform, Lyfebulb, and TRIO (Transplant Recipients International Organization) announced today their partnership to provide the transplant community with the support they need during their journey. Lyfebulb recently launched TransplantLyfe, which enables community members to make connections to each other, share stories, participate in Q&A forums, access information through vetted resources and create journals to track biometrics and other health measurements over time.
Through this partnership, TRIO members will be able to directly link to the TransplantLyfe site from the TRIO website and engage with an international group of transplant patients, care partners, donors and other interested parties. Similarly, TransplantLyfe members will have access to TRIO s expert resour
Share this article
Winning Entry to Receive $25,000 Grant
NEW YORK, Jan. 7, 2021 /PRNewswire/ Lyfebulb, a patient-empowerment platform that connects patients with industry to support user-driven innovation, unveils the launch of their 2021 Innovation Challenge: Thriving with Transplantation. The goal of this initiative is to source innovative solutions to improve outcomes and experiences for all those affected by organ transplantation.
The Innovation Challenge, sponsored by CSL Behring, will take place virtually in May 2021 and is open to patient entrepreneurs – those who have been affected by chronic disease as either a patient or support partner for a loved one and started a company to develop solutions to an unmet need identified in their disease journey.